Abstract: A sealant film used by being laminated on a substrate includes a sealing layer including a first polyolefin resin and an antifogging agent and a first resin layer including 10% to 40% by mass of a cyclic polyolefin resin and 60% to 90% by mass of a second polyolefin resin, wherein the second polyolefin resin is not a cyclic polyolefin resin. The first resin layer is disposed on a surface of the sealing layer, and has a phase-separated structure in which the cyclic polyolefin resin is dispersed in the form of a layer in the second polyolefin resin.

Abstract: A sealant film used by being laminated on a substrate includes a sealing layer including a first polyolefin resin and an antifogging agent and a first resin layer including 50% by mass or more of a cyclic polyolefin resin, wherein the first resin layer is disposed on a surface of the sealing layer.

Abstract: Provided herein are Diaminopyrimidine Compounds having the following structures: wherein R1, R2, R3, and R4 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidine Compound, and methods for treating or preventing liver fibrotic disorders or a condition treatable or preventable by inhibition of a JNK pathway.

Abstract: Provided herein are Aminopurine Compounds having the following structure: wherein R1, R2 and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound and methods for treating or preventing cancer, a cardiovascular disease, a renal disease, an autoimmune condition, an inflammatory condition, macular degeneration, ischemia-reperfusion injury, pain and related syndromes, disease-related wasting, an asbestos-related condition, pulmonary hypertension or a condition treatable or preventable by inhibition of the JNK pathway comprising administering an effective amount of an Aminopurine Compound to a patient in need thereof.

Abstract: Provided herein are Diaminopyrimidine Compounds having the following structures: wherein R1, R2, R3, and R4 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidine Compound, and methods for treating or preventing liver fibrotic disorders or a condition treatable or preventable by inhibition of a JNK pathway.

Abstract: In an ignition coil, a housing has an inner chamber, and a transformer is installed in the inner chamber of the housing. A molded side-core assembly of a transformer includes an arched side core magnetically coupled to first and second ends of a longitudinal center core and located outside a circumferential part of primary and secondary windings. The molded side-core assembly includes an insulation cover molded to cover at least part of the arched side core. The insulation cover has a surface and at least one molding mark formed on the surface thereof. An insulation filler is filled in the inner chamber of the housing while the at least part of the arched side core is exposed from the insulation filler and the at least one molding mark is hermetically sealed in the insulation filler.

Abstract: Provided herein are Aminopurine Compounds having the following structure: wherein R1, R2 and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound and methods for treating or preventing cancer, a cardiovascular disease, a renal disease, an autoimmune condition, an inflammatory condition, macular degeneration, ischemia-reperfusion injury, pain and related syndromes, disease-related wasting, an asbestos-related condition, pulmonary hypertension or a condition treatable or preventable by inhibition of the JNK pathway comprising administering an effective amount of an Aminopurine Compound to a patient in need thereof.

Abstract: Provided herein are Diaminopyrimidine Compounds having the following structures: wherein R1, R2, R3, and R4 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidine Compound, and methods for treating or preventing liver fibrotic disorders or a condition treatable or preventable by inhibition of a JNK pathway.

Abstract: Provided herein are Aminopurine Compounds having the following structure: wherein R1, R2 and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound and methods for treating or preventing cancer, a cardiovascular disease, a renal disease, an autoimmune condition, an inflammatory condition, macular degeneration, ischemia-reperfusion injury, pain and related syndromes, disease-related wasting, an asbestos-related condition, pulmonary hypertension or a condition treatable or preventable by inhibition of the JNK pathway comprising administering an effective amount of an Aminopurine Compound to a patient in need thereof.

Abstract: Provided herein are Diaminopyrimidine Compounds having the following structures: wherein R1, R2, R3, and R4 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidine Compound, and methods for treating or preventing liver fibrotic disorders or a condition treatable or preventable by inhibition of a JNK pathway.

Abstract: The present invention provides an ink jet recording medium which is capable of uniform coating with an ink-receiving agent without a surface treatment step for a usual plastic film used as a base material, and which, due to excellent adhesion , does not cause the problem of peeling after ink jet printing, and does not cause the problem of ink binning, fading, dropout, or peeling or peeling of an ink-receiving layer and an over-coating layer, and also provides a printed material formed by ink jet printing on the ink jet recording medium. The ink jet recording medium including a first layer containing a polyolefin resin as a main component, a second layer containing an acid-modified olefin resin, and an ink-receiving layer is used, the ink-receiving layer being formed by applying an ink-receiving agent on the second layer after the first and second layers are laminated by a coextrusion laminating method.

Abstract: The present invention provides a recording medium for an ink jet ink, which is capable of printing directly with an ink jet ink without a surface treatment step necessary for use of an ordinal plastic film as a substrate and which causes no problem of peeling or the like after printing, and also provides a printed material produced by ink jet printing on the recording medium and a production method therefor. Specifically, printing is performed with various ink jet inks on a layer (A) of a single-layer or multi-layer film (I) used as a recording medium, the layer (A) containing a cyclic polyolefin resin or an acid-modified polyolefin resin.

Abstract: A latex of synthetic polyisoprene and/or a styrene-isoprene-styrene block copolymer with a weight average molecular weight of 10,000 to 5,000,000, a volume average particle size of 0.5 to 10 ?m, and a content of a total of an alicyclic hydrocarbon solvent and aromatic hydrocarbon solvent of 500 weight ppm or less are provided.

Abstract: In an ignition coil, a housing has an inner chamber, and a transformer is installed in the inner chamber of the housing. A molded side-core assembly of a transformer includes an arched side core magnetically coupled to first and second ends of a longitudinal center core and located outside a circumferential part of primary and secondary windings. The molded side-core assembly includes an insulation cover molded to cover at least part of the arched side core. The insulation cover has a surface and at least one molding mark formed on the surface thereof. An insulation filler is filled in the inner chamber of the housing while the at least part of the arched side core is exposed from the insulation filler and the at least one molding mark is hermetically sealed in the insulation filler.

Abstract: The present invention provides a recording medium for an ink jet ink, which is capable of printing directly with an ink jet ink without a surface treatment step necessary for use of an ordinal plastic film as a substrate and which causes no problem of peeling or the like after printing, and also provides a printed material produced by ink jet printing on the recording medium and a production method therefor. Specifically, printing is performed with various ink jet inks on a layer (A) of a single-layer or multi-layer film (I) used as a recording medium, the layer (A) containing a cyclic polyolefin resin or an acid-modified polyolefin resin.

Abstract: Provided herein are Aminopurine Compounds having the following structure: wherein R1, R2 and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound and methods for treating or preventing cancer, a cardiovascular disease, a renal disease, an autoimmune condition, an inflammatory condition, macular degeneration, ischemia-reperfusion injury, pain and related syndromes, disease-related wasting, an asbestos-related condition, pulmonary hypertension or a condition treatable or preventable by inhibition of the JNK pathway comprising administering an effective amount of an Aminopurine Compound to a patient in need thereof.

Abstract: The present invention provides an ink jet recording medium which is capable of uniform coating with an ink-receiving agent without a surface treatment step for a usual plastic film used as a base material, and which, due to excellent adhesion , does not cause the problem of peeling after ink jet printing, and does not cause the problem of ink binning, fading, dropout, or peeling or peeling of an ink-receiving layer and an over-coating layer, and also provides a printed material formed by ink jet printing on the ink jet recording medium. The ink jet recording medium including a first layer containing a polyolefin resin as a main component, a second layer containing an acid-modified olefin resin, and an ink-receiving layer is used, the ink-receiving layer being formed by applying an ink-receiving agent on the second layer after the first and second layers are laminated by a coextrusion laminating method.

Abstract: Provided herein are Diaminopyrimidine Compounds having the following structures: wherein R1, R2, R3, and R4 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidine Compound, and methods for treating or preventing liver fibrotic disorders or a condition treatable or preventable by inhibition of a JNK pathway.

Abstract: Provided herein are Heteroaryl Compounds of formula (I): wherein R1 and R2 are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing inflammatory conditions or cancer, and conditions treatable or preventable by inhibition of a kinase or a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a subject in need thereof.

Abstract: Provided herein are Heteroaryl Compounds of formula (I): wherein R1 and R2 are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing inflammatory conditions or cancer, and conditions treatable or preventable by inhibition of a kinase or a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a subject in need thereof.